J Thivolet
About
In The Last Decade
J Thivolet
524 papers receiving 7.2k citations
Peers
Comparison fields: 5 of 141
- Dermatology 2.2k
- Immunology 2.1k
- Cell Biology 1.7k
- Epidemiology 1.7k
- Molecular Biology 1.3k
Countries citing papers authored by J Thivolet
This map shows the geographic impact of J Thivolet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Thivolet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Thivolet more than expected).
Fields of papers citing papers by J Thivolet
This network shows the impact of papers produced by J Thivolet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Thivolet. The network helps show where J Thivolet may publish in the future.
Co-authorship network of co-authors of J Thivolet
This figure shows the co-authorship network connecting the top 25 collaborators of J Thivolet. A scholar is included among the top collaborators of J Thivolet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Thivolet. J Thivolet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 17 | |
| 2 | 3 | |
| 3 | [Cyclosporine A in dermatology]. | 3 |
| 4 | 18 | |
| 5 | Sarcome de Kaposi et SIDA. | 0 |
| 6 | Long-term treatment of severe psoriasis with low-dose cyclosporin: (2.5 mg/kg/day to 5 mg/kg/day). | 1 |
| 7 | [Harlequin fetus treated with etretin (RO 10-1670)]. | 3 |
| 8 | 2 | |
| 9 | Expression des antigènes HLA de classe II (HLA-DR, DQW1, DQW3) au niveau de la peau normale et en pathologie cutanée | 1 |
| 10 | 5 | |
| 11 | Melanocytes in pigmented macular amyloidosis of the skin | 1 |
| 12 | Hépatite et varicelle. A propos d'un cas. | 1 |
| 13 | Pelade et trisomie 21. A propos de 2 cas. | 1 |
| 14 | [Oral photochemotherapy in vitiligo (author's transl)]. | 2 |
| 15 | La pseudo-porphyrie cutanée tardive des hémodialyses. Aspects cliniques et histologiques à propos de 9 cas | 5 |
| 16 | 18 | |
| 17 | [Paraneoplastic ichthyosis. Ultrastructural study]. | 1 |
| 18 | Pigmentation mélanique essentielle labio-jugale de Laugier. | 3 |
| 19 | Glossite, stomatite et onychopathie provoquées par la pénicillinanine. | 1 |
| 20 | La forme cutanéo-encéphalique de la porphyrie cutanée tardive. | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.